Recurrence of IgA nephropathy after renal transplantation

Annales de Medecine Interne

Volumn 150, Issue 2, 1999, Pages 137-142

  Van Der Boog, Paul J M ^b   De Fijter, Johan W ^b   Bruijn, Jan A ^a   Van Es, Leendert A ^b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

IgA nephrology; Recurrence; Renal transplantation

Indexed keywords

IMMUNOGLOBULIN A;

GRAFT FAILURE; HIGH RISK PATIENT; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY ALLOGRAFT; KIDNEY TRANSPLANTATION; RECURRENT DISEASE; REVIEW; RISK FACTOR;

EID: 0033026987     PISSN: 0003410X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (62)

1. D'AMICO G. The commonest glomerulonephritis in the world: IgA nephropathy. [Review] [153 refs]. Q J Med 1987; 64: 709-27.
2. IBEUS LS, GYORY AZ. IgA nephropathy: analysis of the natural history, important factors in the progression of renal disease, and a review of the literature. [Review] [266 refs]. Medicine (Baltimore) 1994; 73: 79-102.
3. BERGER J, YANEVA H, NABARRA B, BARBANEL C. Recurrence of mesangial deposition of IgA after renal transplantation. Kidney Int 1975; 7: 232-41.
4. SANFILIPPO F, CROKER BP, BOLLINGER RR. Fate of four cadaveric donor renal allografts with mesangial IgA deposits. Transplantation 1982; 33: 370-6.
5. SILVA FG, CHANDER P, PIRANI CL, HARDY MA. Disappearance of glomerular mesangial IgA deposits after renal allograft transplantation [letter]. Transplantation 1982; 33: 241-6.
6. RADFORD MG, DONADIO JV, BERGSTRALH EJ, GRANDE JP. Predicting renal outcome in IgA nephropathy. J Am Soc Nephrol 1997; 8: 199-207.
7. CECKA M. Clinical outcome of renal transplantation. Factors influencing patient and graft survival. [Review] [64 refs]. Surg Clin North Am 1998; 78: 133-48.
8. CECKA JM. Outcome statistics of renal transplants with an emphasis on long-term survival. Clin Transplant 1994; 8(3:Pt 2):Pt 2): 324-7.
9. LAND W. Kidney transplantation-state of the art. [Review] [17 refs]. Transplant Proc 1989; 21(1:Pt 2):Pt 2): 1425-9.
10. BIA MJ. Nonimmunologic causes of late renal graft loss [clinical conference]. Kidney Int 1995; 47: 1470-80.
11. GJERTSON DW. Survival trends in long-term first cadaverdonor kidney transplants. Clin Transpl 1991; 225-35.
12. CAMERON JS. Recurrent primary disease and de novo nephritis following renal transplantation. [Review] [83 refs]. Pediatr Nephrol 1991; 5: 412-21.
13. MATHEW TH. Recurrence of disease following renal transplantation. [Review] [103 refs]. Am J Kidney Dis 1988; 12: 85-96.
14. O'MEARA Y, GREEN A, CARMODY M, DONOHOE J, CAMPBELL E, BROWNE O, WALSHE J. Recurrent glomerulonephritis in renal transplants: fourteen years' experience. Nephrol Dial Transplant 1989; 4:730-4.
15. SCHWARZ A, KRAUSE PH, OFFERMANN G, KELLER F. Recurrent and de novo renal disease after kidney transplantation with or without cyclosporine A. Am J Kidney Dis 1991; 17: 524-31.
16. CAMPISTOL JM, ALMIRALL J, OPPENHEIMER F, RICART MJ, VILARDELL J, ANDREU J. Glomerular disease after kidney transplantation. Transplant Proc 1990; 22: 2275-6.
17. BACHMAN U, BIAVA C, AMEND W, FEDUSKA N, MELZER J, SALVATIERRA O, VINCENTI F. The clinical course of IgA-nephropathy and Henoch-Schonlein purpura following renal transplantation. Transplantation 1986; 42: 511-5.
18. BERGER J, NOEL LH, NABARRA B. Recurrence of mesangial IgA nephropathy after renal transplantation. Contrib Nephrol 1984; 40: 195-7.
19. FROHNERT PP, DONADIO JV, JR., VELOSA JA, HOLLEY KE, STERIOFF S. The fate of renal transplants in patients with IgA nephropathy. Clin Transplant 1997; 11: 127-33.
20. HARTUNG R, LIVINGSTON B, EXCELL L, DISNEY A, WOODROFFE AJ. Recurrence of IgA deposits/disease in grafts. An Australian Registry Survey 1980-1990. Contrib Nephrol 1995; 111: 13-6.
21. KESSLER M, HIESSE C, HESTIN D, MAYEUX D, BOUBENIDER K, CHARPENTIER B. Recurrence of immunoglobulin A nephropathy after renal transplantation in the cyclosporine era. Am J Kidney Dis 1996; 28: 99-104.
22. KIM YS, JEONG HJ, CHOI KH, KIM MS, LEE HY, HAN DS, PARK K. Renal transplantation in patients with IgA nephropathy. Transplant Proc 1996; 28: 1543-4.
23. ODUM J, PEH CA, CLARKSON AR, BANNISTER KM, SEYMOUR AE, GILLIS D, THOMAS AC, MATHEW TH, WOODROFFE AJ. Recurrent mesangial IgA nephritis following renal transplantation. Nephrol Dial Transplant 1994; 9: 309-12.
24. OHMACHT C, KLIEM V, BURG M, NASHAN B, SCHLITT HJ, BRUNKHORST R, KOCH KM, FLOEGE J. Recurrent immunoglobulin A nephropathy after renal transplantation: a significant contributor to graft loss. Transplantation 1997; 64: 1493-6.
25. BUMGARDNER GL, AMEND WC, ASCHER NL, and VINCENT FG. Single-center long-term results of renal transplantation for IgA nephropathy. Transplantation 1998; 65: 1053-60.
26. KOSELJ M, ROTT T, VIZJAK A, KVEDER R. IgA nephropathy as a donor-transmitted disease in renal transplant recipients. Transplant Proc 1991; 23: 2643-6.
27. TOLKOFF-RUBIN NE, COSIMI AB, FULLER T, RUBLIN RH, COLVIN RB. IGA nephropathy in HLA-identical siblings. Transplantation 1978; 26: 430-3.
28. KOSELJ M, ROTT T, KANDUS A, VIZJAK A, MALOVRH M. Donor-transmitted IgA nephropathy: long-term follow-up of kidney donors and recipients. Transplant Proc 1997; 29: 3406-7.
29. SUGIYAMA S, YAMAMOTO T, TSUYUKI M, OHSHIMA S. [Study of IgA nephropathy in the transplanted kidney - sequential changes in mesangial IgA deposits found one hour post-transplantation kidney biopsies]. [Japanese]. Nippon Jinzo Gakkai Shi 1986; 28: 729-37.
30. DE LA RIVIERE GB, VAN DE PUTTE LB. Preexisting glomerulonephritis in allografted kidneys. Occurrence in man. Arch Pathol Lab Med 1976; 100: 196-8.
31. SMITH SM, HARFORD AM. IgA nephropathy in renal allografts: increased frequency in Native American patients. Renal Failure 1995; 17: 449-56.
32. SUGANUMA T, MOROZUMI K, SATOH K, YOSIDA A, FUJINAMI T, UCHIDA K, YAMADA N, ORIHARA A, TANAKA Y, SHINMURA I, et al. Studies of IgA nephropathy in renal transplantation. Transplant Proc 1989; 21(1:Pt 2):Pt 2): 2123-7.
33. CUEVAS X, LLOVERAS J, MIR M, AUBIA J, MASRAMON J. Disappearance of mesangial IgA deposits from the kidneys of two donors after transplantation. Transplant Proc 1987; 19(1:Pt 3):Pt 3): 2208-9.
34. JONES B, NANRA RS, HIBBERD AD, WHITE K. Resolution of IgA nephropathy after renal allograft transplantation [letter]. Clin Nephrol 1990; 33: 53.
35. CURSCHELLAS E, LANDMANN J, DURIG M, HUSER B, KYO M, BASLER V, THIEL G, MIHATSCH MJ. Morphologic findings in "zero-hour" biopsies of renal transplants. Clin Nephrol 1991; 36: 215-22.
36. ROSENBERG HG, VIAL SU, MARTINEZ LV, MARTINEZ PS, AGUILO JM, CISTERNAS MM. Berger's disease in living-related donors. Transplant Proc 1995; 27: 1809-10.
37. CERILLI J, HOLLIDAY JE, WILSON CB, SHARMa HM. Clinical significance of the 1-hour biopsy in renal transplantation. Transplantation 1978; 26: 91-3.
38. HAYASHI I, AIKAWA A, MIZUIRI S, et al. Clinical features of IgA nephropathy in renal transplantation. [Abstract] Abstracts, IgA Nephropathy "The 25th year" Symposium, Nancy, France, 1992.
39. PARK SB, JOO I, SUK J, CHO WH, PARK CH, KIM SP, PARK KK, KIM HC. IgA nephropathy in renal transplant recipients: is it a significant cause of allograft failure? Transplantation Proceedings 1996; 28: 1540-2.
40. BRENSILVER JM, MALLAT S, SCHOLES J, MCCABE R. Recurrent IgA nephropathy in living-related donor transplantation: recurrence or transmission of familial disease? Am J Kidney Dis 1988; 12: 147-51.
41. DIAZ-TEJEIRO R, MADUELL F, DIEZ J, ESPARZA N, ERRASTI P, PURROY A, PARDO J. Loss of renal graft due to recurrent IgA nephropathy with rapidly progressive course: an unusual clinical evolution. Nephron 1990; 54: 341-3.
42. MARCEN R, PASCUAL J, FELIPE C, MAMPASO F, GONZALO A, OROFINO L, ORTUNO J. Recurrence of IgA nephropathy with nephrotic syndrome after kidney transplantation. Nephron 1991; 59: 486-9.
43. PETTERSSON E, HONKANEN E, TORNROTH T. Recurrence of IgA nephropathy with nephrotic syndrome in renal allograft. Nephron 1985; 41: 114-7.
44. MATHEW TH, MATHEWS DC, HOBBS JB, KINCAID-SMITH P. Glomerular lesions after renal transplantation. Am J Med 1975; 59: 177-90.
45. FELLNER SK, PAPATHEOFANIS JA, YU B. IgA nephropathy in three successive renal allografts: presumed recurrence of original disease. Am J Nephrol 1994; 14: 64-6.
46. KIMATA N, TANABE K, ISHIKAWA N, OZU H, SONDA K, YUMURA W, TOMA H, NIHEI H, OTA K, TAKAHASHI K. Correlation between proteinuria and prognosis of transplant IgA nephropathy. Transplant Proc 1996; 28: 1537-9.
47. BERGER J. Recurrence of IgA nephropathy in renal allografts. Am J Kidney Dis 1988; 12: 371-2.
48. PARK SB, JOO I, PARK KA, CHO WH, PARK CH, KIM SP, PARK KK, KIM HC. Rapidly progressive glomerulonephritis in a renal transplant with recurrent IgA nephropathy. Transplantation Proceedings 1996; 28: 1529-30.
49. ROBLES NR, GOMEZ CAMPDERA FJ, ANAYA F, NIEMBRO DE RASCHE E, GALAN A, RENGEL MA, VALDERRABANO F. IgA nephropathy with rapidly progressive course after kidney transplantation [letter]. Nephron 1991; 58: 487-8.
50. Streather CP, Scoble JE. Recurrent IgA nephropathy in a renal allograft presenting as crescentic glomerulonephritis [letter]. Nephron 1994; 66: 113-4.
51. LIM EC AND TERASAKI PI. High survival rate of kidney transplants in IgA nephropathy patients. Clin Transplant 1992; 6: 100-5.
52. LIM EC, CHIA D, GJERTSON DW, KOKA P, TERASAKI PI. In vitro studies to explain high renal allograft survival in IgA nephropathy patients. Transplantation 1993; 55: 996-9.
53. ALAMARTINE E, BOULHAROUZ J, BERTHOUX F. Actuarial survival rate of kidney transplants in patients with IgA glomerulonephritis: a one-center study. Transplant Proc 1994; 26: 272.
54. FREESE P, NORDEN G, OLAUSSON M, NYBERG G. Rejection rates in kidney transplant patients with and without IgA nephropathy. Nephrol Dial Transplant 1997; 12: 2385-8.
55. COPPO R, AMORE A, CIRINA P, MESSINA M, BASOLO B, SEGOLONI G, BERTHOUX F, BOULAHROUZ R, EGIDO J, ALCAZAR R, et al. Characteristics of IgA and macromolecular IgA in sera from IgA nephropathy transplanted patients with and without IgAN recurrence. Contrib Nephrol 1995; 111: 85-92.
56. TOMLANOVICH S, VINCENTI F, AMEND W, BIAVA C, MELZER J, FEDUSKA N, SALVATIERRA O. Is cyclosporine effective in preventing recurrence of immune-mediated glomerular disease after renal transplantation? Transplant Proc 1988; 20(3:Suppl 4):Suppl 4): 285-8.
57. VAN ES LA, DE FIJTER JW, DAHA MR. Pathogenesis of IgA nephropathy. Nephrology 1997; 3: 3-12.
58. EGIDO J, JULIAN BA, WYATT RJ. Genetic factors in primary IgA nephropathy. Nephrol Dial Transplant 1987; 2: 134-42.
59. SCHENA FP, SCIVITTARO V, RANIERI E. Abnormalities of the IgA immune system in members of unrelated pedigrees from patients with IgA nephropathy. Clin Exp Immunol 1993; 92: 139-44.
60. NOEL LH, DESCAMPS B, JUNGERS P, BACH JF, BUSSON M, SUET C, HORS J, DAUSSET J. HLA antigen in three types of glomerulonephritis. Clin Immunol Immunopathol 1978; 10: 19-23.
61. FROHNERT PP, VELOSA JA, DONADIO JV, STERIOFF S. Renal transplantation in IgA nephropathy: the effect of HLA matching on recurrence of primary disease. Transplant Proc 1994; 26: 1892.
62. HOTTA O, CHIBA S, FURUTA T, SUDOU K, HORIGOME I, TAGUMA Y. Clinicopathological study of IgA nephropathy in patients with congenitally reduced nephron mass. Clin Nephrol 1995; 44: 362-6.